×

img Accessibility Controls

Research Banner
Total Records: 281

Filter Research

Title Research Area Implementing Organisations Funding Organisations Start Year Status
A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India Pharmaceutical Sciences Lifecare Innovations Private Limited, Gurgaon, Haryana Department of Science and Technology (DST) 2024 ongoing
In silico discovery and biological evaluation of potential drug molecules to improve the treatment of Bedaquiline and Delamanid resistance in Mycobacterium tuberculosis. Pharmaceutical Sciences University of Hyderabad Department of Science and Technology (DST) 2024 ongoing
Preparation and Characterization of Novel Formulations of Nepafenac for the Management of Ocular Inflammation. Pharmaceutical Sciences Panjab University Department of Science and Technology (DST) 2024 ongoing
pH-Responsive Biodegradable Nanogels for Controlled and Targeted Drug Delivery Systems Pharmaceutical Sciences Tripura University Department of Science and Technology (DST) 2024 ongoing
Biopolymeric Porous Carriers Through Assembly of Emulsion Templating and Microfluidics for Controlled Delivery of Drugs and Therapeutics Pharmaceutical Sciences National Institute of Technology (Jalandhar), Punjab Anusandhan National Research Foundation (ANRF) 2024 Ongoing
On Design and Analysis of Stepped Wedge Cluster Randomized Trials Pharmaceutical Sciences Indian Institute of Science Science and Engineering Research Board (SERB), New Delhi 2024 Ongoing
NIR Light Controlled Activity Of Antibiotics By Using Upconversion Nanoparticles Pharmaceutical Sciences Indian Institute of Science Science and Engineering Research Board (SERB), New Delhi 2024 ongoing
Pharmacological Intervention using α-Klotho with AT1 Receptor Blocker and Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitor against Diabetic Kidney Disease Pharmaceutical Sciences Birla Institute of Technology and Science Anusandhan National Research Foundation (ANRF) 2024 ongoing
Determination of In Vivo Effective Diffusion Rates of Therapeutics from Controlled Release Systems Pharmaceutical Sciences Indian Institute of Science Science and Engineering Research Board (SERB), New Delhi 2024 ongoing
Substantiation of PI3K/Akt Signaling Pathway in Alzheimer’s disease employing Pharmacological Strategies and their Nano-formulations Pharmaceutical Sciences Chaudhary Bansi Lal University Anusandhan National Research Foundation (ANRF) 2024 ongoing
arrowtop
Latest Updates
Loading…